198 related articles for article (PubMed ID: 2051328)
1. Physical properties of the complexes formed between heptakis(2,6-di-O-methyl)-beta-cyclodextrin, beta-cyclodextrin, and chlorambucil.
Green AR; Miller ES; Guillory JK
J Pharm Sci; 1991 Feb; 80(2):186-9. PubMed ID: 2051328
[TBL] [Abstract][Full Text] [Related]
2. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
Green AR; Guillory JK
J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
[TBL] [Abstract][Full Text] [Related]
5. Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin in solution and in the solid state.
Cafaggi S; Vallarino M; Caviglioli G; Parodi B; Bignardi G
J Pharm Pharmacol; 1998 Mar; 50(3):257-64. PubMed ID: 9600716
[TBL] [Abstract][Full Text] [Related]
6. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
[TBL] [Abstract][Full Text] [Related]
7. Improvement of dissolution characteristics of psoralen by cyclodextrins complexation.
Vincieri FF; Mazzi G; Mulinacci N; Bambagiotti-Alberti M; Dall' Acqua F; Vedaldi D
Farmaco; 1995; 50(7-8):543-7. PubMed ID: 7669193
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
[TBL] [Abstract][Full Text] [Related]
10. Interactions of griseofulvin with cyclodextrins in solid binary systems.
Veiga MD; Díaz PJ; Ahsan F
J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
[TBL] [Abstract][Full Text] [Related]
11. Study of glimepiride-b-cyclodextrin complex.
Moyano JR; Ventriglia T; Ginés JM; Muñoz F; Rabasco AM
Boll Chim Farm; 2003 Nov; 142(9):390-5. PubMed ID: 14971307
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Physicochemical Characterization of an Inclusion Complex Between Dimethylated β-Cyclodextrin and a Drug Lead From a New Class of Orally Active Antimalarial 3,5-Diaryl-2-Aminopyridines.
Joseph LM; Chibale K; Caira MR
J Pharm Sci; 2016 Nov; 105(11):3344-3350. PubMed ID: 27640751
[TBL] [Abstract][Full Text] [Related]
14. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex.
Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G
Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865
[TBL] [Abstract][Full Text] [Related]
16. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
17. Inclusion phenomena of clove oil with alpha-, beta-, gamma- and heptakis (2,6-di-O-methyl)-beta-cyclodextrin.
Song LX; Xu P; Wang HM; Yang Y
Nat Prod Res; 2009; 23(9):789-800. PubMed ID: 19306153
[TBL] [Abstract][Full Text] [Related]
18. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
Zhang YM; Li X; Sun CS; Chen CF
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450
[TBL] [Abstract][Full Text] [Related]
19. Chlorophyll a in cyclodextrin supramolecular complexes as a natural photosensitizer for photodynamic therapy (PDT) applications.
Semeraro P; Chimienti G; Altamura E; Fini P; Rizzi V; Cosma P
Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():47-56. PubMed ID: 29407156
[TBL] [Abstract][Full Text] [Related]
20. Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies.
Sbârcea L; Tănase IM; Ledeți A; Cîrcioban D; Vlase G; Barvinschi P; Miclău M; Văruţ RM; Trandafirescu C; Ledeți I
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
